Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Abstract Text:

    johanna m m van oersJohanna M M van Oers,peter j wildPeter J Wild,maximilian burgerMaximilian Burger,stefan denzingerStefan Denzinger,robert stoehrRobert Stoehr,elke rosskopfElke Rosskopf,ferdinand hofstaedterFerdinand Hofstaedter,ewout w steyerbergEwout W Steyerberg,monika klinkhammer-schalkeMonika Klinkhammer-Schalke,ellen c zwarthoffEllen C Zwarthoff,theodorus h van der kwastTheodorus H van der Kwast,arndt hartmannArndt Hartmann,johanna m m van oersJohanna M M van Oers,peter j wildPeter J Wild,maximilian burgerMaximilian Burger,stefan denzingerStefan Denzinger,robert stoehrRobert Stoehr,elke rosskopfElke Rosskopf,ferdinand hofstaedterFerdinand Hofstaedter,ewout w steyerbergEwout W Steyerberg,monika klinkhammer-schalkeMonika Klinkhammer-Schalke,ellen c zwarthoffEllen C Zwarthoff,theodorus h van der kwastTheodorus H van der Kwast,arndt hartmannArndt Hartmann,

    OBJECTIVES: Molecular markers superior to conventional clinicopathologic parameters are needed to predict disease courses in bladder cancer patients. In this study, we investigated four markers (Ki-67, TP53, CK20, FGFR3) in primary urothelial bladder tumours and compared them with traditional pathologic features. METHODS: Tissue microarrays were used to analyse CK20, TP53, and Ki-67 expression immunohistochemically in 255 unselected patients. FGFR3 mutations were detected by SNaPshot analysis. RESULTS: Abnormal CK20 expression was strongly associated with higher tumour grades and stages (p < 0.001); however, 65% of pTa tumours revealed an abnormal CK20 pattern. In the group of pTaG1 tumours, 59% presented with an abnormal CK20 pattern, whereas 82% carried the FGFR3 mutation. In the group of bladder tumours with normal CK20 pattern, the FGFR3 gene was mutated in 89%, whereas a mutated FGFR3 gene was found in only 37% of cases with abnormal CK20 expression (p < 0.001). All markers proved to be strong predictors of disease-specific survival in univariate studies. However, in multivariate analyses they were not independent from classical pathologic parameters. None of the molecular markers was significantly associated with tumour recurrence. CONCLUSIONS: Dysregulation of CK20 expression is an early event in the carcinogenesis of papillary noninvasive bladder cancer, but occurs later than FGFR3 mutations. The group of low-grade noninvasive papillary tumours is defined by the presence of an FGFR3 mutation and a normal CK20 expression pattern.

    FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Publishing Authors By Initials

    jm van oersJM van Oers,pj wildPJ Wild,m burgerM Burger,s denzingerS Denzinger,r stoehrR Stoehr,e rosskopfE Rosskopf,f hofstaedterF Hofstaedter,ew steyerbergEW Steyerberg,m klinkhammer-schalkeM Klinkhammer-Schalke,ec zwarthoffEC Zwarthoff,th van der kwastTH van der Kwast,a hartmannA Hartmann,jm van oersJM van Oers,pj wildPJ Wild,m burgerM Burger,s denzingerS Denzinger,r stoehrR Stoehr,e rosskopfE Rosskopf,f hofstaedterF Hofstaedter,ew steyerbergEW Steyerberg,m klinkhammer-schalkeM Klinkhammer-Schalke,ec zwarthoffEC Zwarthoff,th van der kwastTH van der Kwast,a hartmannA Hartmann,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: European urology

    VOLUME: 52

    Page Numbers: 760-8

    Journal Abbreviation: Eur. Urol.

    ISSN: 0302-2838

    DAY: 12

    MONTH: 01

    YEAR: 2007

    FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7512719

    FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

    AFFILIATION: Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Eur Urol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News